Biogen (BIIB) Cash & Current Investments (2009 - 2026)
Biogen's Cash & Current Investments was $1.3 billion in Q3 2026, down 67.1% from $3.96 billion a year earlier but up 1.5% from the prior quarter.
Biogen (BIIB) Cash & Current Investments (2009 - 2026) Analysis & Trends
At the end of FY2025, Cash & Current Investments at Biogen came in at $3.82 billion, up 60.7% from FY2024.
- Cash & Current Investments shows a five-year compound annual growth rate of 7.9% (FY2020 to FY2025).
- In earlier years, Cash & Current Investments was $2.38 billion in FY2024 (+126.2%), $1.05 billion in FY2023 (-78.5%), $4.89 billion in FY2022 (+28.7%) and $3.8 billion in FY2021 (+45.7%).
- Quarterly Cash & Current Investments has moved between $1.05 billion (Q4 2023) and $6.08 billion (Q2 2023) over five years.
- Compared with a year earlier, Cash & Current Investments was higher in six of the last eight quarters, with growth averaging 56.3%.
- The best year-over-year quarter for Cash & Current Investments over five years was Q1 2025 (growth of 141.8%); the worst was Q1 2024 (a decline of 78.7%).
- Per Business Quant data, BIIB's Cash & Current Investments in the three quarters before Q3 2026 was $1.29 billion (Q2 2026), $4.28 billion (Q1 2026) and $3.82 billion (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | 505.00 Mn |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 8.17 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 14.27 Bn |
| 10 | Biogen | 37.46 Bn | 26.77 Bn | 2.06 Bn | 1.30 Bn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.30 Bn |
| Jun 30, 2026 | 1.29 Bn |
| Mar 31, 2026 | 4.28 Bn |
| Dec 31, 2025 | 3.82 Bn |
| Sep 30, 2025 | 3.96 Bn |
| Jun 30, 2025 | 2.76 Bn |
| Mar 31, 2025 | 2.60 Bn |
| Dec 31, 2024 | 2.38 Bn |
| Sep 30, 2024 | 1.70 Bn |
| Jun 30, 2024 | 1.91 Bn |
| Mar 31, 2024 | 1.07 Bn |
| Dec 31, 2023 | 1.05 Bn |
| Sep 30, 2023 | 2.29 Bn |
| Jun 30, 2023 | 6.08 Bn |
| Mar 31, 2023 | 5.04 Bn |
| Dec 31, 2022 | 4.89 Bn |
| Sep 30, 2022 | 4.91 Bn |
| Jun 30, 2022 | 4.80 Bn |
| Mar 31, 2022 | 3.75 Bn |
| Dec 31, 2021 | 3.80 Bn |
Biogen Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=BIIB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();